A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx
Business Trip, a podcast about psychedelic entrepreneurship
Welcome back to Business Trip, a podcast about psychedelic entrepreneurship! 🍄
In this episode, we discuss:
The science, experience, and the safety profile of ibogaine’s “neurochemical reset”
Navigating US drug regulatory system and securing Intellectual Property
Deborah’s 30 year journey through Amsterdam, Miami and the Caribbean aiming to get Ibogaine therapy approved
Partnership with ATAI Life Sciences
Business Trip tells the story of the emerging industry of psychedelics. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.
Thanks for listening,
💖 Know someone who would enjoy Business Trip?